Based on cross-trial data, CagriSema and tirzepatide produce nearly identical weight loss results, approximately 22 to 23% in non-diabetic populations with obesity
Water Research, 237: 119985 Zhang Y, Wu H, Xu R, Wang Y, Chen L, Wei C (2024)
weeks 9 to 12+ use 2.0 mg or 6 units
We offer a variety of well-trialed peptide stacks designed to support recovery, inflammation reduction, tissue healing, and overall wellness
5-Amino-1MQ peptide therapy is an emerging treatment that targets metabolic pathways differently than conventional options
If your goal is to reduce abdominal fat, the path still runs through a sustainable calorie deficit, consistent training, adequate sleep, and proper nutrition